M C W Pharma Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 09-12-2024
- Paid Up Capital ₹ 2.24 M
as on 09-12-2024
- Company Age 36 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.92 M
as on 09-12-2024
- Revenue %
(FY 2022)
- Profit 100.00%
(FY 2022)
- Ebitda 98.34%
(FY 2022)
- Net Worth
- Total Assets %
(FY 2022)
About M C W Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.24 M.
The company currently has active open charges totaling ₹3.92 M.
Abhijeet Motiwale, Sharan Simon, and Amit Chawla serve as directors at the Company.
- CIN/LLPIN
U24232MP1988PTC004693
- Company No.
004693
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jul 1988
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at M C W Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sharan Simon  | Director | 17-Aug-2022 | Current |
| Abhijeet Motiwale | Director | 17-Aug-2022 | Current |
| Amit Chawla | Director | 10-Apr-2018 | Current |
Financial Performance and Corporate Structure Insights of M C W Pharma.
M C W Pharma Pvt Ltd, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 100% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of M C W Pharma?
Unlock access to M C W Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Mcw Healthcare Private LimitedActive 24 years 8 monthsAbhijeet Motiwale, Sharan Simon and 1 more are mutual person
Maxtra Global Private LimitedActive 7 years 11 monthsAbhijeet Motiwale, Sharan Simon and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of Saurashtra Creation Date: 14 Jul 1997 | ₹2.20 M | Open |
State Bank Of Saurashtra Creation Date: 25 May 1993 | ₹1.40 M | Open |
State Bank Of Saurashtra Creation Date: 16 Feb 1990 | ₹0.32 M | Open |
How Many Employees Work at M C W Pharma?
Unlock and access historical data on people associated with M C W Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of M C W Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped M C W Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
